Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions
- PMID: 39115856
- PMCID: PMC11310841
- DOI: 10.1001/jama.2024.11437
Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions
Abstract
Importance: Serious cutaneous adverse drug reactions (cADRs) are potentially life-threatening drug hypersensitivity reactions involving the skin and internal organs. Antibiotics are a recognized cause of these reactions, but no studies have compared relative risks across antibiotic classes.
Objectives: To explore the risk of serious cADRs associated with commonly prescribed oral antibiotics, and to characterize outcomes of patients hospitalized for them.
Design, setting, and participants: Nested case-control study using population-based linked administrative datasets among adults aged 66 years or older who received at least 1 oral antibiotic between 2002 and 2022 in Ontario, Canada. Cases were those who had an emergency department (ED) visit or hospitalization for serious cADRs within 60 days of the prescription, and each case was matched with up to 4 controls who did not.
Exposure: Various classes of oral antibiotics.
Main outcomes and measures: Conditional logistic regression estimate of the association between different classes of oral antibiotics and serious cADRs, using macrolides as the reference group.
Results: During the 20-year study period, we identified 21 758 older adults (median age, 75 years; 64.1% female) who had an ED visit or hospitalization for serious cADRs following antibiotic therapy and 87 025 matched controls who did not. In the primary analysis, sulfonamide antibiotics (adjusted odds ratio [aOR], 2.9; 95% CI, 2.7-3.1) and cephalosporins (aOR, 2.6; 95% CI, 2.5-2.8) were most strongly associated with serious cADRs relative to macrolides. Additional associations were evident with nitrofurantoin (aOR, 2.2; 95% CI, 2.1-2.4), penicillins (aOR, 1.4; 95% CI, 1.3-1.5), and fluoroquinolones (aOR, 1.3; 95% CI, 1.2-1.4). The crude rate of ED visits or hospitalization for cADRs was highest for cephalosporins (4.92 per 1000 prescriptions; 95% CI, 4.86-4.99) and sulfonamide antibiotics (3.22 per 1000 prescriptions; 95% CI, 3.15-3.28). Among the 2852 case patients hospitalized for cADRs, the median length of stay was 6 days (IQR, 3-13 days), 9.6% required transfer to a critical care unit, and 5.3% died in the hospital.
Conclusion and relevance: Commonly prescribed oral antibiotics are associated with an increased risk of serious cADRs compared with macrolides, with sulfonamides and cephalosporins carrying the highest risk. Prescribers should preferentially use lower-risk antibiotics when clinically appropriate.
Conflict of interest statement
Similar articles
-
Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.Cutan Ocul Toxicol. 2017 Dec;36(4):370-376. doi: 10.1080/15569527.2017.1301947. Epub 2017 Apr 19. Cutan Ocul Toxicol. 2017. PMID: 28423957
-
Emergency department visits for antibiotic-associated adverse events.Clin Infect Dis. 2008 Sep 15;47(6):735-43. doi: 10.1086/591126. Clin Infect Dis. 2008. PMID: 18694344
-
Outpatient gatifloxacin therapy and dysglycemia in older adults.N Engl J Med. 2006 Mar 30;354(13):1352-61. doi: 10.1056/NEJMoa055191. Epub 2006 Mar 1. N Engl J Med. 2006. PMID: 16510739
-
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.Am J Med. 2010 Apr;123(4 Suppl):S26-38. doi: 10.1016/j.amjmed.2010.02.004. Am J Med. 2010. PMID: 20350633 Review.
-
Single-use antibiotics for the pediatric patient in the emergency department.Pediatr Emerg Care. 2005 Jan;21(1):50-9; quiz 60-2. doi: 10.1097/01.pec.0000150990.03981.d0. Pediatr Emerg Care. 2005. PMID: 15643327 Review. No abstract available.
Cited by
-
The characteristics and clinical course of patients with melioidosis and cancer.PLoS Negl Trop Dis. 2024 Oct 25;18(10):e0012631. doi: 10.1371/journal.pntd.0012631. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39453944 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
